short acting glp 1 GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Diabetes, obesity, and possible actions

Given the excitement surrounding them, social media is full of food concoctions and supplements touted as natural GLP-1s or natures Ozempic. But do they really work and are they even safe

Yet, only 5% of U.S

The finding of distinct central populations of Gipr -expressing neurones in the AP and hypothalamus underlying responses to agonism and antagonism, respectively, goes some way towards resolving the dilemma of agonism and antagonism having similar outcomes

In recent years, research has discovered the potential effects of GLP-1 and its analogs on the nervous system, particularly in relation to the bloodbrain barrier (BBB)

doi: 10.1186/s12916-022-02477-z

The prevalence of hypertension was low (16.80%), as were the historical incidences of cardiovascular disease (9.51%) and prior lipid-lowering therapy (14.37%)